{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:59:26Z","timestamp":1773665966112,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cgfr.co.uk","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cytogfr.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T14:12:57Z","timestamp":1463580777000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["New polyprenyl phosphate based preparation Fortepren\u00ae as promising cytokine regulationg antiviral remedy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-9783","authenticated-orcid":false,"given":"Alexander V.","family":"Pronin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander N.","family":"Narovlyansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey E.","family":"Shulzhenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Sanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Sedov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2016.04.001_bib0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later a golden journey","volume":"119","author":"Aggarwa","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0010","first-page":"15","article-title":"The clinical management of recurrent genital herpes: current issues and future prospects","volume":"9","author":"Barton","year":"2002","journal-title":"Herpes"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0015","first-page":"395","article-title":"Phosprenyl a novel drug with antiviral and immunomodulatory activity","volume":"44","author":"Danilov","year":"1996","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0020","unstructured":"L.L. Danilov, A.V. Deyeva, T. Kuritz, S.D. Maltsev, A.N. Narovlianskiy, A.V. Pronin, A.V. Sanin, O. Sosnovskaya, S.V. Ozherelkov, Therapeutic composition and methods US patent No. 6525035 (2003) Feb. 25."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/jir.2014.0227","article-title":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections","volume":"35","author":"Davidson","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0030","first-page":"72","article-title":"Phosprenyl\u2014structure biological properties, clinical effects","volume":"1","author":"Deyeva","year":"2005","journal-title":"Mezhdunarodny Vestnik Veterinarii"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/medethics-2012-100894","article-title":"Herpes genitalis and the philosopher's stance","volume":"40","author":"Dunphy","year":"2014","journal-title":"J. Med. Ethics"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4110\/in.2014.14.4.187","article-title":"Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus","volume":"14","author":"Erdenebileg","year":"2014","journal-title":"Immune Netw."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/rmv.1791","article-title":"Immune escape of \u03b3-herpesviruses from adaptive immunity","volume":"24","author":"Hu","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/icb.2014.1","article-title":"The unconventional expression of IL-15 and its role in NK cell homeostasis","volume":"92","author":"Huntington","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.abb.2011.10.018","article-title":"At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl phosphates","volume":"517","author":"Hartley","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.11613\/BM.2012.019","article-title":"Insight into complexity of congenital disorders of glycosylation","volume":"22","author":"Goreta","year":"2012","journal-title":"Biochem. Med. (Zagreb.)"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009036.pub2","article-title":"Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients","volume":"8","author":"Le Cleach","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0075","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1128\/MCB.05251-11","article-title":"Stochastic receptor expression determines cell fate upon interferon treatment","volume":"31","author":"Levin","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","article-title":"Chemokines as regulators of T cell differentiation","volume":"2","author":"Luther","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0085","article-title":"Interleukin-2 and STAT5 in regulatory T cell development and function","volume":"2","author":"Mahmud","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2015.07.009","article-title":"The paradoxical role of IL-10 in immunity and cancer","volume":"367","author":"Mannino","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0095","first-page":"256","article-title":"Fortepren\u2014a novel perspective anti-herpetic and immunomodulating preparation based on polyprenyl phosphates","volume":"2","author":"Narovlyansky","year":"2008","journal-title":"Russ. Immunol. J."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0100","first-page":"81","article-title":"Antiviral activity of polyprenyl phosphates in experimental infection caused by hepatitis C virus in vitro","volume":"5","author":"Narovlianski\u012d","year":"2012","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0105","first-page":"54","article-title":"Antiviral activity and possible mechanisms of action of moraprenyl phosphates during experimental infection caused by herpes simplex type 1 virus","volume":"5","author":"Narovlyansky","year":"2014","journal-title":"J. Microbiol. Epidemiol. Immunobiol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0110","unstructured":"On the experimental study of Fortepren\u00ae safety\/\/Report of N.F. Gamaleya Inst. for Epidemiology and Microbiology, Moscow (2005) 127 p."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/08977194.2011.590138","article-title":"Evolution of IL4 and pathogen antagonism","volume":"29","author":"Pillai","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0120","first-page":"135","article-title":"Polyprenols as possible factors that determine an instructive role of the innate immunity in the acquired immune response","volume":"7","author":"Pronin","year":"2002","journal-title":"Russ. J. Immunol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.15789\/2220-7619-2012-3-645-650","article-title":"Polyprenyl phosphates as adjuvants, polarizing the immune response to Th1","volume":"2","author":"Pronin","year":"2012","journal-title":"Infect. Immun. (Russ.)"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00005-013-0253-y","article-title":"Plant polyisoprenoids and control of cholesterol levels","volume":"62","author":"Pronin","year":"2014","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10354-014-0321-x","article-title":"IL-6 blockade in chronic inflammatory diseases","volume":"165","author":"Puchner","year":"2015","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","article-title":"Tumor necrosis factor blockade and the risk of viral infection","volume":"6","author":"Seo","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0150","first-page":"381","article-title":"Genital herpes\u2013epidemiological and clinical issue still of importance","volume":"64","author":"Serwin","year":"2010","journal-title":"Przegl. Epidemiol."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/593757","article-title":"Evasion of early antiviral responses by herpes simplex viruses","author":"Suazo","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cell.2011.06.048","article-title":"Structural linkage between ligand discrimination and receptor activation by type I interferons","volume":"19","author":"Thomas","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4110\/in.2014.14.4.187","article-title":"Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus","volume":"14","author":"Uyangaa","year":"2014","journal-title":"Immune Netw."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0170","first-page":"3","article-title":"Antiviral and immunomodulating activity of polyprenyl phosphates in viral infections","volume":"53","author":"Vasil'ev","year":"2008","journal-title":"Antibiot. Khimioter."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0175","unstructured":"I. Yamatsu, T. Suzuki, S. Abe, K. Nakamoto, A. Kajiwara, K. Katayama, H. Tsunoda, M. Murakami, H. Ono, K. Yamada, Therapeutic and Preventive Agent Containing Dolichol, United States Patent (1986) 4.613.593."},{"key":"10.1016\/j.cytogfr.2016.04.001_bib0180","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cytogfr.2015.07.003","article-title":"Interleukin-12: Functional activities and implications for disease","volume":"26","author":"Zundler","year":"2015","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610116300181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610116300181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T16:43:10Z","timestamp":1567874590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610116300181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"alternative-id":["S1359610116300181"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2016.04.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New polyprenyl phosphate based preparation Fortepren\u00ae as promising cytokine regulationg antiviral remedy","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}